FERLAZZO, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 7.646
Totale 7.646
Nazione #
IT - Italia 7.646
Totale 7.646
Città #
Genova 4.955
Genoa 1.039
Vado Ligure 962
Rapallo 670
Bordighera 20
Totale 7.646
Nome #
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. 180
A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells 162
Mucosal Immunology and Probiotics. 147
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 147
Detection of MAGE-1, -2, and -3 messenger RNA in tissue samples derived from lung and mammary tumors. 146
Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors. 142
Dendritic cell editing by natural killer cells. 138
Human dendritic cells activate resting Natural Killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. 134
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 133
Novel perspectives on dendritic cell-based immunotherapy of cancer 132
T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties 132
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 130
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 130
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells 126
Characterization of human afferent lymph dendritic cells from seroma fluids. 125
IFN-alpha mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome 124
Human NK cells and NK receptors 124
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 122
Surface receptors and functional interactions of human natural killer cells: from bench to the clinic 121
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 121
Seroma fluid subsequent to axillary lymph node dissection for breast cancer derives from an accumulation of afferent lymph. 120
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 119
Dendritic cells efficiently cross-prime HLA class I restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. 117
Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer. 117
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells 117
Adherent neoplastic cells grown at confluence downregulate HLA class I expression and enhance their susceptibility to lysis mediated by natural killer cells. 116
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. 115
The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell ig-like receptors and become cytolytic. 115
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 110
Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. 109
Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells 109
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 108
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 108
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. 107
Effector and regulatory events during natural killer-dendritic cell interactions 105
Do NK cells play a role in the possible association between natalizumab treatment and the development of melanoma? 105
The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production. 104
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. 103
The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells 102
Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses 101
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 101
Role of natural killer cells in the pathogenesis and progression of multiple sclerosis 100
Human natural killer cell function and their interactions with dentritic cells. 98
Cognate HLA absence in trans diminishes human NK cell education 97
Targeting ctla-4 directly on melanoma cells: A possible novel perspective in the immunotherapy of cutaneous melanoma. 96
Amniotic fluid contains multipotent mesenchymal stromal cells with high proliferative potential and safety features: solid perspectives for clinical application 92
Symptomatic carotid atherosclerotic plaques are associated with increased infiltration of natural killer (NK) cells and higher serum levels of NK activating receptor ligands 90
Morphological, phenotypic and karyotypic characterization of a novel natural-killer-cell target - evidence of involvement of MHC class-I molecules in NK cell recognition. 89
NK cells at the interface between innate and adaptive immunity 85
Update on natural killer cells: cross-talk with dendritic cells and role in the cure of acute myeloid leukemias. 84
The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2. 84
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. 81
Heterogeneity of the alpha-interferon-mediated overexpression of class-I and class-II major histocompatibility complex molecules in primary cultured cancer cells. 76
NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion 76
Natural Killer cells infiltrating human non-small cell lung cancer are enriched in CD56bright CD16- cells and display an impaired capability to kill tumor cells 74
Treatment of superficial bladder cancer with intravesical perfusion of rIL-2: a follow-up study. 68
Mechanical bacterial lysate administration prevents exacerbation in allergic asthmatic children—The EOLIA study 67
The engagement of ctla-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and tnf-alpha production. 64
Il recettore CTLA-4 è espresso dalle cellule dendritiche umane e ne regola le funzioni. 55
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 54
Myeloma cells induce the accumulation of activated CD94low NK cells by cell-to-cell contacts involving CD56 molecules 52
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade 52
Vitamin D plasma level can affect nivolumab drug exposure in a cohort of patients with non-small-cell lung cancer 48
Cognate HLA absence diminishes human NK cell education in trans 44
Dendritic Cell-Based Immunotherapy of Cancer: Current Pitfalls and Challenges 25
Mechanical bacterial lysate enhances antimicrobial barrier mechanisms in human airway epithelial cells 25
A PHASE-I STUDY OF INTRAVESICAL CONTINUOUS PERFUSION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH SUPERFICIAL BLADDER- CANCER 24
A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 22
Adaptative immunotherapy of advanced solid tumors 22
Acquisition and presentation of tumor antigens by dendritic cells 21
Changes in plasma 5-HT levels and equine leukocyte SERT expression in response to treadmill exercise 21
Clinical drug response to thiopurines is associated with a lower interferon-γ production by IBD patient’s T lymphocytes 19
NK cell compartments and their activation by dendritic cells 19
Biological parameters in breast cancer 19
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 18
An historical overview: The discovery of how NK cells can kill enemies, recruit defense troops, and more 18
CLASS-I HLA AND ICAM-1 MOLECULE EXPRESSION IN PRIMARY CULTURED CANCER-CELLS DECREASES IN A STATIONARY-PHASE OF CELL-GROWTH 17
Oxidative stress induces Wnt canonical/non-canonical pathways modulation in colon cancer cell models 17
Identification of Natural Killer Cells in Tissues and Their Isolation 17
SPONTANEOUS TRANSFORMATION AND IMMORTALIZATION OF PERITONEAL- MACROPHAGES OF HUMAN-ORIGIN 16
Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells 16
Analysis of HLA-class-I specific natural killer cell receptors expressed on T lymphocytes infiltrating non-small-cell lung cancer 16
Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15 16
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 16
Crosstalk between ILC3s and Microbiota: Implications for Colon Cancer Development and Treatment with Immune Check Point Inhibitors 16
Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells 16
Cytotoxic effects of high energy shock waves on cancer cells linked to metallic beads vehicled by monoclonal antibodies 15
Chitosan/hyaluronan nanoparticles: a promising tool in cancer immunotherapy 15
Raman spectroscopy is able to discriminate between CD138-/CD138+ plasmacells of multiple myeloma patients 15
The Yin and Yang of Innate Lymphoid Cells in Cancer 15
EMODERIVATO IN FORMA DI GEL COMPRENDENTE FIBRINA, PIASTRINE E LEUCOCITI 15
Drag cells in immunity: Plasmacytoid DCs dress up as cancer cells 14
Evaluation of the canonical/non-canonical Wnt signalling pathways during oxidative stress in colorectal cancer cell line models 14
Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-kB pathways 14
A multivariate analysis of Multiple Myeloma subtype plasma cells 14
Isolation and Analysis of Human Natural Killer Cell Subsets 14
Interactions between natural killer and dendritic cells during bacterial infections 13
Divergent signaling pathways regulate IL-12 production induced by different species of Lactobacilli in human dendritic cells 13
Developmental properties of dendritic cell progenitors 13
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer 13
Totale 7.363
Categoria #
all - tutte 28.127
article - articoli 26.788
book - libri 37
conference - conferenze 688
curatela - curatele 0
other - altro 0
patent - brevetti 100
selected - selezionate 0
volume - volumi 514
Totale 56.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.302 0 0 0 0 0 191 271 123 170 281 211 55
2020/2021501 34 66 42 15 41 43 20 34 45 51 63 47
2021/2022830 30 74 59 81 35 49 54 206 48 67 34 93
2022/2023881 72 71 15 63 112 129 3 58 130 6 211 11
2023/2024915 19 64 38 164 96 227 19 31 37 38 73 109
2024/20251.000 35 215 118 103 306 223 0 0 0 0 0 0
Totale 7.846